| Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy C Rajagopal, MB Lankadasari, JM Aranjani, KB Harikumar Pharmacological Research 130, 273-291, 2018 | 112 | 2018 |
| TAMing pancreatic cancer: combat with a double edged sword MB Lankadasari, P Mukhopadhyay, S Mohammed, KB Harikumar Molecular cancer 18, 1-13, 2019 | 79 | 2019 |
| Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine MB Lankadasari, JS Aparna, S Mohammed, S James, K Aoki, VS Binu, ... Theranostics 8 (14), 3824, 2018 | 75 | 2018 |
| Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression S James, JS Aparna, AM Paul, MB Lankadasari, S Mohammed, VS Binu, ... Scientific reports 7 (1), 13945, 2017 | 47 | 2017 |
| Genomic mapping of metastatic organotropism in lung adenocarcinoma HB Lengel, B Mastrogiacomo, JG Connolly, KS Tan, Y Liu, CN Fick, ... Cancer Cell 41 (5), 970-985. e3, 2023 | 26 | 2023 |
| Artificial intelligence in microbial natural product drug discovery: current and emerging role VJ Sahayasheela, MB Lankadasari, VM Dan, SG Dastager, GN Pandian, ... Natural product reports 39 (12), 2215-2230, 2022 | 23 | 2022 |
| Enhanced expression of histone chaperone APLF associate with breast cancer A Majumder, KM Syed, A Mukherjee, MB Lankadasari, JM Azeez, ... Molecular cancer 17, 1-9, 2018 | 20 | 2018 |
| Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity S Mohammed, NS Vineetha, S James, JS Aparna, MB Lankadasari, ... FASEB journal: official publication of the Federation of American Societies …, 2020 | 18 | 2020 |
| Cardamonin attenuates experimental colitis and associated colorectal cancer S James, JS Aparna, A Babu, AM Paul, MB Lankadasari, SR Athira, ... Biomolecules 11 (5), 661, 2021 | 16 | 2021 |
| Acid ceramidase: a novel therapeutic target in cancer Y Vijayan, MB Lankadasari, KB Harikumar Current topics in medicinal chemistry 19 (17), 1512-1520, 2019 | 16 | 2019 |
| Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus S Mohammed, NS Vineetha, S James, JS Aparna, MB Lankadasari, ... The FASEB Journal 33 (6), 7061, 2019 | 11 | 2019 |
| Targeting Acid Ceramidase enhances antitumor immune response in colorectal cancer Y Vijayan, S James, A Viswanathan, JS Aparna, A Bindu, NN Namitha, ... Journal of Advanced Research, 2023 | 3 | 2023 |
| COVID-19: A Centennial Pandemic from Origin to Clinical Trials RR Vidwans, MB Lankadasari Acta Biologica Marisiensis 3 (1), 30-52, 2020 | 3 | 2020 |
| A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos Y Liu, N Chudgar, B Mastrogiacomo, D He, MB Lankadasari, S Bapat, ... Science translational medicine 14 (665), eabo1050, 2022 | 2 | 2022 |
| BRMS1 downregulation alters the tumor microenvironment and induces immunotherapy resistance in lung adenocarcinoma MB Lankadasari, Y Liu, B Mastrogiacomo, Y Zhu, EG Dunne, CN Fick, ... Cancer Research 84 (6_Supplement), 6596-6596, 2024 | | 2024 |
| Longitudinal analyses of clinical sequencing data provide novel insights into the evolutionary dynamics of lung adenocarcinoma B Mastrogiacomo, EG Dunne, CN Fick, J Nguyen, J Hathwar, ... Cancer Research 84 (6_Supplement), 2556-2556, 2024 | | 2024 |
| Genomic profiling and metastatic risk in early-stage non–small cell lung cancer CN Fick, EG Dunne, MB Lankadasari, B Mastrogiacomo, T Asao, ... JTCVS open 16, 9-16, 2023 | | 2023 |
| BRMS1 alters the tumor inflammatory signature and immune infiltration in lung adenocarcinoma MB Lankadasari, Y Liu, D He, S Bapat, B Mastrogiacomo, HB Lengel, ... Cancer Research 82 (12_Supplement), 3142-3142, 2022 | | 2022 |
| Abrogation of Pancreatic Cancer Using a Brain Malady Drug MB Lankadasari, AS Jayasekharan, S Mohammed, S James, K Aoki, ... The FASEB Journal 33 (S1), 796.7-796.7, 2019 | | 2019 |
Dr K B HarikumarRajiv Gandhi Centre for Biotechnology (RGCB)Verified email at rgcb.res.in
